Clinical Trials Directory

Trials / Completed

CompletedNCT03479073

Risk Factors of Stroke or Systemic Embolism After Atrial Fibrillation Ablation

The Characteristics of Patients Experiencing Stroke or Systemic Embolism During Follow up Period After Atrial Fibrillation Ablation

Status
Completed
Phase
Study type
Observational
Enrollment
3,198 (actual)
Sponsor
Korea University Guro Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

To investigate the rate and risk factors of stroke or systemic embolism (SE) following atrial fibrillation (AF) ablation.

Detailed description

Since catheter ablation for AF reduces the burden of AF effectively, several studies have demonstrated that catheter ablation not only improves the quality of life but also reduces the risk of stroke and all cause mortality. However, until now the guideline has recommended the continuation of oral anticoagulation (OAC) therapy in patients who are at risk of stroke or systemic embolism (SE) based on the CHA2DS2-VASc score, even though they have sinus rhythm following catheter ablation. The aims of this retrospective study is to assess the rate of stroke/SE during follow-up period after AF ablation and identify the independent risk factors for stroke/SE in patients who underwent catheter ablation for AF.

Conditions

Timeline

Start date
2017-05-17
Primary completion
2018-06-14
Completion
2018-06-14
First posted
2018-03-27
Last updated
2018-06-18

Locations

3 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03479073. Inclusion in this directory is not an endorsement.